Perfromance Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.06M Buy
4,419
+117
+3% +$119K 0.12% 37
2025
Q4
$4.62M Buy
4,302
+538
+14% +$514K 0.13% 32
2025
Q3
$2.87M Sell
3,764
-25,941
-87% -$19.3M 0.08% 40
2025
Q2
$23.2M Sell
29,705
-4,262
-13% -$3.31M 0.74% 18
2025
Q1
$28.1M Sell
33,967
-36,087
-52% -$30M 1% 15
2024
Q4
$54.1M Sell
70,054
-144
-0.2% -$119K 1.74% 11
2024
Q3
$62.2M Buy
70,198
+3,697
+6% +$3.32M 2.14% 8
2024
Q2
$60.2M Buy
66,501
+32,547
+96% +$26M 2.22% 9
2024
Q1
$26.4M Buy
33,954
+16,567
+95% +$11.8M 1.11% 12
2023
Q4
$10.1M Buy
17,387
+2,481
+17% +$1.45M 0.45% 20
2023
Q3
$8.01M Buy
14,906
+1,539
+12% +$793K 0.39% 25
2023
Q2
$6.23M Buy
13,367
+1,973
+17% +$827K 0.29% 31
2023
Q1
$3.91M Buy
11,394
+4,032
+55% +$1.36M 0.2% 40
2022
Q4
$2.69M Buy
7,362
+2,574
+54% +$913K 0.16% 43
2022
Q3
$1.55M Sell
4,788
-15
-0.3% -$4.75K 0.09% 54
2022
Q2
$1.56M Buy
4,803
+1,108
+30% +$333K 0.09% 57
2022
Q1
$1.06M Buy
3,695
+276
+8% +$71K 0.05% 73
2021
Q4
$944K Buy
+3,419
New +$867K 0.04% 85

Other funds holding LLY

Perfromance Wealth Partners's LLY Position: Q1 2026 in Review

Perfromance Wealth Partners increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $119K and bringing the position to 4,419 shares worth $4.06M. The position accounts for 0.12% of the portfolio, ranked #37.

Perfromance Wealth Partners first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $62.2M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Perfromance Wealth Partners held 4,419 shares of Eli Lilly worth $4.06M as of Q1 2026.
  • Perfromance Wealth Partners bought 117 Eli Lilly shares in Q1 2026, an estimated $119K.
  • Eli Lilly made up 0.12% of Perfromance Wealth Partners's portfolio in Q1 2026, its #37 holding.
  • Perfromance Wealth Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Perfromance Wealth Partners's Eli Lilly position peaked at $62.2M in Q3 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.